Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Disparities 2010: Interview with Howard K. Koh, M.D., M.P.H

October 1, 2010 9:32 am | by AACR | News | Comments

Disparities 2010: Interview with Howard K. Koh, M.D., M.P.H., assistant secretary for health, U.S. Department of Health and Human Services

TOPICS:

Health Management acquires 2 Florida hospitals

October 1, 2010 8:45 am | by The Associated Press | News | Comments

Health Management Associates acquired Wuesthoff Health System, which runs two hospitals in eastern Florida, for $152 million.The hospital operator said Friday that Wuesthoff runs one hospital in Rockledge with 298 beds, and one in Melbourne with 115 beds. It said the deal is effective Friday....

Stocks waver after data shows growth remains slow

October 1, 2010 7:45 am | by STEPHEN BERNARD - AP Business Writer - Associated Press | News | Comments

Signs of slowing growth in manufacturing kept investors' enthusiasm in check Friday as the final quarter of the year got under way.The Dow Jones industrial average rose 22 points in late morning trading after the Institute for Supply Management said its manufacturing index fell modestly in...

Advertisement

Phase III Data Showing Improved Survival With Jevtana® (cabazitaxel) Injection in Second-Line Advanced Prostate Cancer Published in The Lancet

October 1, 2010 7:34 am | by Bio-Medicine.Org | News | Comments

BRIDGEWATER, N.J., Oct. 1 /- Sanofi-aventis (EURONEXT: SAN and NYSE: SNY ) announced today that data from the Phase III TROPIC study, which was the basis for the June 2010 U.S. Food and Drug Administration (FDA) approval of Jevtana® (cabazitaxel) Injection, was published in the...

TOPICS:

VirtualScopics Revenues Hit Another Quarterly Record

October 1, 2010 7:34 am | by Bio-Medicine.Org | News | Comments

ROCHESTER, N.Y., Oct. 1 /- VirtualScopics, Inc. (Nasdaq: VSCP ), a provider of quantitative imaging for clinical trials, today announced revenues for the third quarter ended September 30, 2010 exceeded $3.5 million, representing a greater than 25% increase over the comparable period in...

TOPICS:

Elekta Launches ABAS 2.0 Autosegmentation Software Used to Plan Radiation Therapy in Patients With Cancer

October 1, 2010 7:34 am | by Bio-Medicine.Org | News | Comments

ATLANTA, Oct. 1 /- Elekta recently launched ABAS ( Atlas-based Autosegmentation ) 2.0 software, which includes the Simultaneous Truth and Performance Level Estimation (STAPLE) algorithm to increase contouring accuracy. ABAS—considered the industry gold standard for autosegmentation...

TOPICS:

Cancer Health Disparities: Challenges and Opportunities

October 1, 2010 7:34 am | by AACR | News | Comments

Disparities 2010: “Cancer Health Disparities: Challenges and Opportunities” includes perspectives from numerous Congressional officials, Federal agency leaders and a clinician on possible policy prescriptions that are necessary to help reduce cancer health disparities.

TOPICS:

BD to Establish Major Distribution Center in Four Oaks, North Carolina

October 1, 2010 7:32 am | by Becton, Dickinson and Company | News | Comments

(October 01, 2010) -- BD (Becton, Dickinson and Company), a leading global medical technology company, today announced plans to construct a new East Coast distribution center in Four Oaks, North Carolina. The $38 million investment project is expected to generate n

TOPICS:
Advertisement

Consumer Information on: Abbott RealTime HBV Assay - P080026

October 1, 2010 7:31 am | by U.S. Food & Drug Administration | News | Comments

Abbott RealTime HBV is a laboratory test kit that measures the amount of hepatitis B viral DNA in the blood of an individual infected by the hepatitis B virus (HBV). Viral DNA is the genetic material from the hepatitis B virus.

TOPICS:

Summary Information for: Abbott RealTime HBV Assay(2)

October 1, 2010 7:31 am | by U.S. Food & Drug Administration | News | Comments

Labeling, Approval Order, and Summary of Safety and Effectiveness for Abbott RealTime HBV Assay (P080026).

TOPICS:

Summary Information for: Abbott RealTime HBV Assay

October 1, 2010 7:30 am | News | Comments

Labeling, Approval Order, and Summary of Safety and Effectiveness for Abbott RealTime HBV Assay (P080026).

Manu Platt Wins $1.5M NIH Director's New Innovator Award

October 1, 2010 6:32 am | by Georgia Tech Institute of Technology | News | Comments

Manu Platt from the biomedical engineering department at Georgia Tech and Emory University has received a $1.5 million NIH Director's New Innovator Award to support a project aimed at reducing the incidence of stroke in children with sickle cell disease.

TOPICS:

ALS Research Gets a $4.1 Million Boost from CVS/pharmacy Fundraising Campaign

October 1, 2010 6:31 am | by Bio-Medicine.Org | News | Comments

WOONSOCKET, R.I., Oct. 1 /- In just 21 days, CVS/pharmacy's ninth annual in-store fundraising campaign to support the fight against amyotrophic lateral sclerosis (ALS) brought in $4.1 million. The funds raised by the campaign will be donated to the Boston-based ALS Therapy Alliance (ATA)...

TOPICS:

DaVita offering $1.45 billion in senior notes

October 1, 2010 3:45 am | by The Associated Press | News | Comments

DaVita Inc. will $1.45 billion in senior notes, the kidney dialysis services provider said Friday.The company said it intends to use the proceeds to buy or redeem its outstanding 6 5/8 percent senior notes due 2013 and 7 1/4 percent senior subordinated notes due 2015.Banc of America Securities...

Mylan Launches Generic Version of Wellbutrin XL® Tablets

October 1, 2010 3:32 am | by Bio-Medicine.Org | News | Comments

PITTSBURGH, Oct. 1 /- Mylan Inc. (Nasdaq: MYL ) today announced that its subsidiary Mylan Pharmaceuticals Inc. has launched Bupropion Hydrochloride Extended-release Tablets USP, (XL), 150 mg and 300 mg (Once-Daily), the generic version of GlaxoSmithKline's antidepressant Wellbutrin XL...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading